It has been reported that miltirone reduced intracellular reactive oxygen species (ROS), leading to cell pyroptosis, and inhibited tumor growth through suppressing phosphorylation of MEK and ERK1/2 in the HCC (Zhang et al., 2020). The gene discussed is MAPK3; the disease is hepatocellular carcinoma.